Compumedics Limited (CMP.AX)
AUD 0.29
(-1.03%)
AUD 0.29
(-1.03%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 2.78 Million AUD | 155.18% |
| 2023 | -5.05 Million AUD | -286.88% |
| 2022 | 1.34 Million AUD | -27.28% |
| 2021 | 2.56 Million AUD | 104.3% |
| 2020 | -5.41 Million AUD | -84.01% |
| 2019 | 5.77 Million AUD | 43.55% |
| 2018 | 4.17 Million AUD | 128.27% |
| 2017 | 2.69 Million AUD | -50.23% |
| 2016 | 4.84 Million AUD | 16.11% |
| 2015 | 4.06 Million AUD | 60.46% |
| 2014 | 3 Million AUD | 441.06% |
| 2013 | 342 Thousand AUD | -464.95% |
| 2012 | -156 Thousand AUD | -113.88% |
| 2011 | 602 Thousand AUD | -28.96% |
| 2010 | 1.52 Million AUD | -73.63% |
| 2009 | 3.69 Million AUD | 167.07% |
| 2008 | 1.94 Million AUD | -4.25% |
| 2007 | 1.44 Million AUD | 253.26% |
| 2006 | -7000.00 AUD | 59.52% |
| 2005 | -2.35 Million AUD | -174.71% |
| 2004 | 3.13 Million AUD | 442.17% |
| 2003 | -920 Thousand AUD | -44.65% |
| 2002 | -428.92 Thousand AUD | -120.92% |
| 2001 | 4.22 Million AUD | 2676.27% |
| 2000 | -118 Thousand AUD | -105.98% |
| 1999 | 1.97 Million AUD | 42.73% |
| 1998 | 1.38 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | 117.89% |
| 2024 Q2 | 758 Thousand AUD | 0.0% |
| 2024 Q4 | -307 Thousand AUD | 0.0% |
| 2023 Q2 | -5.04 Million AUD | 0.0% |
| 2023 Q4 | 4.05 Million AUD | 0.0% |
| 2023 FY | - AUD | -286.88% |
| 2022 Q4 | 1.61 Million AUD | 0.0% |
| 2022 Q2 | -269 Thousand AUD | 0.0% |
| 2022 FY | - AUD | -27.28% |
| 2021 Q4 | -56 Thousand AUD | 0.0% |
| 2021 FY | - AUD | 104.3% |
| 2021 Q2 | 1.91 Million AUD | 0.0% |
| 2020 Q4 | -423 Thousand AUD | 0.0% |
| 2020 Q2 | 1.4 Million AUD | 0.0% |
| 2020 FY | - AUD | -84.01% |
| 2019 FY | - AUD | 43.55% |
| 2019 Q4 | 4.08 Million AUD | 0.0% |
| 2019 Q2 | 1.31 Million AUD | 0.0% |
| 2018 FY | - AUD | 128.27% |
| 2018 Q4 | 2.85 Million AUD | 0.0% |
| 2018 Q2 | 1.1 Million AUD | 0.0% |
| 2017 Q4 | 1.16 Million AUD | 0.0% |
| 2017 FY | - AUD | -50.23% |
| 2017 Q2 | 564 Thousand AUD | 0.0% |
| 2016 Q2 | 1.67 Million AUD | 0.0% |
| 2016 FY | - AUD | 16.11% |
| 2016 Q4 | 1.8 Million AUD | 0.0% |
| 2015 Q4 | 1.79 Million AUD | 0.0% |
| 2015 FY | - AUD | 60.46% |
| 2015 Q2 | 1.2 Million AUD | 0.0% |
| 2014 Q2 | 689 Thousand AUD | 0.0% |
| 2014 FY | - AUD | 441.06% |
| 2014 Q4 | 1.18 Million AUD | 0.0% |
| 2013 FY | - AUD | -464.95% |
| 2013 Q2 | -70 Thousand AUD | 0.0% |
| 2013 Q4 | -478 Thousand AUD | 0.0% |
| 2012 FY | - AUD | -113.88% |
| 2012 Q3 | -24.25 Thousand AUD | 0.0% |
| 2012 Q2 | -24.25 Thousand AUD | -113.88% |
| 2012 Q1 | 174.75 Thousand AUD | 0.0% |
| 2012 Q4 | -24.25 Thousand AUD | 0.0% |
| 2011 Q3 | 174.75 Thousand AUD | 0.0% |
| 2011 Q4 | 174.75 Thousand AUD | 0.0% |
| 2011 FY | - AUD | -28.96% |
| 2011 Q1 | 334.5 Thousand AUD | 0.0% |
| 2011 Q2 | 174.75 Thousand AUD | -47.76% |
| 2010 Q2 | 334.5 Thousand AUD | -64.12% |
| 2010 Q3 | 334.5 Thousand AUD | 0.0% |
| 2010 Q4 | 334.5 Thousand AUD | 0.0% |
| 2010 FY | - AUD | -73.63% |
| 2010 Q1 | 932.25 Thousand AUD | 0.0% |
| 2009 FY | - AUD | 167.07% |
| 2009 Q4 | 932.25 Thousand AUD | 0.0% |
| 2009 Q2 | 932.25 Thousand AUD | 91.33% |
| 2009 Q1 | 487.25 Thousand AUD | 0.0% |
| 2009 Q3 | 932.25 Thousand AUD | 0.0% |
| 2008 Q1 | 364.75 Thousand AUD | 0.0% |
| 2008 FY | - AUD | -4.25% |
| 2008 Q4 | 487.25 Thousand AUD | 0.0% |
| 2008 Q3 | 487.25 Thousand AUD | 0.0% |
| 2008 Q2 | 487.25 Thousand AUD | 33.58% |
| 2007 FY | - AUD | 253.26% |
| 2007 Q4 | 364.75 Thousand AUD | 0.0% |
| 2007 Q3 | 364.75 Thousand AUD | 0.0% |
| 2007 Q2 | 364.75 Thousand AUD | 20942.86% |
| 2007 Q1 | -1750.00 AUD | 0.0% |
| 2006 Q1 | -1.56 Million AUD | 0.0% |
| 2006 Q3 | -1750.00 AUD | 0.0% |
| 2006 Q4 | -1750.00 AUD | 0.0% |
| 2006 FY | - AUD | 59.52% |
| 2006 Q2 | -1750.00 AUD | 99.89% |
| 2005 Q3 | -1.56 Million AUD | 0.0% |
| 2005 Q2 | -1.56 Million AUD | -212.71% |
| 2005 Q4 | -1.56 Million AUD | 0.0% |
| 2005 Q1 | 1.38 Million AUD | 0.0% |
| 2005 FY | - AUD | -174.71% |
| 2004 Q3 | 1.38 Million AUD | 0.0% |
| 2004 Q2 | 1.38 Million AUD | 128.47% |
| 2004 Q4 | 1.38 Million AUD | 0.0% |
| 2004 Q1 | -4.86 Million AUD | 0.0% |
| 2004 FY | - AUD | 442.17% |
| 2003 FY | - AUD | -44.65% |
| 2003 Q4 | -4.86 Million AUD | 0.0% |
| 2003 Q3 | -4.86 Million AUD | 0.0% |
| 2003 Q2 | -4.86 Million AUD | -666.73% |
| 2003 Q1 | -635.03 Thousand AUD | 0.0% |
| 2002 Q3 | -635.03 Thousand AUD | 0.0% |
| 2002 Q4 | -635.03 Thousand AUD | 0.0% |
| 2002 FY | - AUD | -120.92% |
| 2002 Q1 | 1.34 Million AUD | 0.0% |
| 2002 Q2 | -635.03 Thousand AUD | -147.36% |
| 2001 Q2 | 1.34 Million AUD | 2617.93% |
| 2001 FY | - AUD | 2676.27% |
| 2001 Q3 | 1.34 Million AUD | 0.0% |
| 2001 Q1 | -53.25 Thousand AUD | 0.0% |
| 2001 Q4 | 1.34 Million AUD | 0.0% |
| 2000 Q4 | -53.25 Thousand AUD | 0.0% |
| 2000 Q2 | -53.25 Thousand AUD | -106.68% |
| 2000 Q3 | -53.25 Thousand AUD | 0.0% |
| 2000 Q1 | 797.25 Thousand AUD | 0.0% |
| 2000 FY | - AUD | -105.98% |
| 1999 Q2 | 797.25 Thousand AUD | 55.49% |
| 1999 FY | - AUD | 42.73% |
| 1999 Q4 | 797.25 Thousand AUD | 0.0% |
| 1999 Q1 | 512.75 Thousand AUD | 0.0% |
| 1999 Q3 | 797.25 Thousand AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1998 Q2 | 512.75 Thousand AUD | 0.0% |
| 1998 Q3 | 512.75 Thousand AUD | 0.0% |
| 1998 Q4 | 512.75 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 107.733% |
| Adherium Limited | -11.56 Million AUD | 124.117% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 137.894% |
| Atomo Diagnostics Limited | -5.42 Million AUD | 151.424% |
| Anteris Technologies Ltd | -66.9 Million AUD | 104.169% |
| Control Bionics Limited | -5.15 Million AUD | 154.069% |
| CardieX Limited | -6.71 Million AUD | 141.553% |
| Cochlear Limited | 579.5 Million AUD | 99.519% |
| CleanSpace Holdings Limited | -3.49 Million AUD | 179.873% |
| Cyclopharm Limited | -3.03 Million AUD | 191.898% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | 233.368% |
| Nova Eye Medical Limited | -5.97 Million AUD | 146.647% |
| HeraMED Limited | -3.97 Million AUD | 170.215% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 112.752% |
| ImpediMed Limited | -22.05 Million AUD | 112.648% |
| InhaleRx Limited | -1.41 Million AUD | 297.278% |
| LBT Innovations Limited | -4.04 Million AUD | 168.881% |
| Micro-X Limited | -14.35 Million AUD | 119.434% |
| Neurotech International Limited | -8.24 Million AUD | 133.831% |
| OncoSil Medical Limited | -11.97 Million AUD | 123.288% |
| PolyNovo Limited | 5.17 Million AUD | 46.054% |
| Respiri Limited | -7.04 Million AUD | 139.561% |
| SomnoMed Limited | -2.32 Million AUD | 219.771% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 130.681% |
| Uscom Limited | -1.5 Million AUD | 284.786% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | 156.717% |